β¨ Medicines Act Notices
8 OCTOBER NEW ZEALAND GAZETTE 4063
Medicines Act 1981
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Lamivudine 150 mg | Tablet, film coated | Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom | 3TC |
| Lamivudine 10 mg/mL | Solution, oral | Glaxo Wellcome Operations, Speke, Liverpool, United Kingdom | 3TC |
| Losartan potassium 12.5 mg, 50 mg | Tablet, film coated | Merck Sharp & Dohme Limited, Cramlington, Northumberland, England | Cozaar |
| Carvedilol 3.125 mg, 6.25 mg, 12.5 mg, 25 mg | Tablets | Boehringer Mannheim GmbH., Mannheim, Germany | Dilatrend |
| Recombinant human erythropoietin 2000IU, 3000IU, 4000IU, 10000IU (phosphate buffered) | Injection, solution, pre-filled syringe | Cilag AG., Schaffhausen, Switzerland; Janssen Pharmaceutica nv., Beerse, Belgium and Vetter Pharma-Fertigung GmbH. & Co KG., Ravensburg, Germany | Eprex |
| Recombinant human erythropoietin 1000IU, 2000IU, 3000IU, 4000IU, 10000IU (citrate buffered) | Injection, solution, vial | F Hoffmann-La Roche Limited, Switzerland; and Janssen Pharmaceutica nv., Beerse, Belgium | Eprex |
Dated this 29th day of September 1998.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
go7094
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Antazoline hydrochloride 0.5 mg/mL, tetrahydrozoline hydrochloride 0.4 mg/mL | Drops, eye, solution | Laboratoires Ciba Vision Faure, Annonay Cedex, France | In A Wink Allergy Eye Drops |
| Naphazoline nitrate 0.05 mg/mL, zinc sulphate 0.2 mg/mL | Drops, eye, solution | Laboratoires Ciba Vision Faure, Annonay Cedex, France | In A Wink Eye Drops |
| Zopiclone 7.5 mg | Tablet, film coated | Gerard Laboratories, Dublin, Eire | Zo-Tab |
Dated this 29th day of September 1998.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
go7095
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1998, No 170
NZLII —
NZ Gazette 1998, No 170
β¨ LLM interpretation of page content
π₯ Consent to Distribution of Changed Medicines
π₯ Health & Social Welfare29 September 1998
Medicines, Distribution, Consent, Lamivudine, Losartan, Carvedilol, Erythropoietin
- G. R. Boyd, Chief Advisor, Regulation and Safety
π₯ Consent to Distribution of New Medicine
π₯ Health & Social Welfare29 September 1998
Medicines, Distribution, Consent, Antazoline, Naphazoline, Zopiclone
- G. R. Boyd, Chief Advisor, Regulation and Safety